List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 106 studies with search of: Open Studies | "Vomiting"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Depth of Hypnosis and Postoperative Nausea and Vomiting During Xenon Anaesthesia
Conditions: Anaesthetics Gases, Xenon;   Anaesthetics Volatile, Sevoflurane;   Depth of Anaesthesia;   Postoperative Nausea;   Postoperative Vomiting
Interventions: Drug: Xenon;   Drug: Sevoflurane;   Drug: Dexamethasone;   Drug: NaCl;   Drug: Ondansetron
2 Recruiting A Multicenter, Open-Label, Single-Arm Evaluation of Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Who Have Experienced CINV(Chemotherapy-Induced Nausea and Vomiting) During the Previous Cycle of Low Emetogenic Chemotherapy (LEC)
Condition: Patients With Confirmed Malignant Disease to Receive Low Emetogenic Chemotherapy (LEC) or Who Experienced at Least Nausea and Vomiting During Last Cycle of LEC
Intervention: Drug: palonesetron
3 Not yet recruiting Oral Aprepitant and Lower Dose Dexamethasone Versus Aprepitant Alone for Preventing Postoperative Nausea and Vomiting (PONV) After Elective Laparoscopic Surgeries
Conditions: Nausea;   Vomiting
Interventions: Drug: Dexamethasone;   Drug: Aprepitant;   Drug: Placebo Dexamethasone
4 Recruiting Late Onset Postoperative Nausea and Vomiting
Condition: Postoperative Nausea and Vomiting
Interventions: Drug: Placebo;   Drug: Ondansetron, Dexamethasone;   Drug: Midazolam, dexamethasone
5 Recruiting Comparison of Aprepitant Versus Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting
Conditions: Nausea;   Vomiting
Interventions: Drug: Aprepitant;   Drug: Scopolamine
6 Recruiting A Randomized, Double-Blind Comparison of Oral Aprepitant Alone Versus Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting
Conditions: Nausea;   Vomiting
Interventions: Drug: Emend (Aprepitant) + Placebo;   Drug: Scopolamine + Emend (Aprepitant)
7 Not yet recruiting Management of Nausea and Vomiting of Pregnancy
Conditions: Hyperemesis Gravidarum;   Nausea;   Vomiting;   Pregnancy
Interventions: Procedure: Day care;   Procedure: Inpatient
8 Not yet recruiting Does Acupressure Help Reduce Nausea and Vomiting in Palliative Care Patients? Formal Study
Conditions: Nausea;   Vomiting
Interventions: Device: Acupressure Wrist Bands (Sea-Bands);   Device: Placebo wristbands
9 Recruiting Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy
Conditions: Nausea and Vomiting;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: fosaprepitant dimeglumine;   Drug: systemic chemotherapy;   Other: survey administration;   Procedure: quality-of-life assessment
10 Not yet recruiting Fosaprepitant for Breakthrough Chemotherapy Induced Nausea and Vomiting
Conditions: Nausea;   Vomiting
Intervention: Drug: fosaprepitant
11 Recruiting Gabapentin in the Prevention of Nausea and Vomiting Induced by Chemotherapy
Conditions: Vomiting;   Cisplatin;   Antineoplastic Combined Chemotherapy Protocols
Interventions: Drug: Placebo;   Drug: Gabapentin
12 Recruiting Effectiveness of Aprepitant in Addition to Ondansetron in the Prevention of Nausea and Vomiting Caused by Upper Abdominal Radiotherapy
Conditions: Nausea;   Vomiting
Interventions: Drug: aprepitant;   Drug: Ondansetron
13 Recruiting Study of the Effect of Intramuscular Ephedrine on the Incidence of Nausea and Vomiting During Elective Cesarean Section
Conditions: Nausea;   Vomiting;   Cesarean Section
Interventions: Drug: Ephedrine [Synonyms: Ephedra, Ephedrinum];   Drug: Saline Placebo
14 Recruiting Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer
Conditions: Anal Cancer;   Carcinoma of the Appendix;   Colorectal Cancer;   Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Gastric Cancer;   Gastrointestinal Carcinoid Tumor;   Liver Cancer;   Nausea and Vomiting;   Pancreatic Cancer;   Peritoneal Cavity Cancer;   Small Intestine Cancer
Interventions: Drug: palonosetron hydrochloride;   Other: placebo
15 Recruiting Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing a Stem Cell Transplant
Conditions: Breast Cancer;   Chronic Myeloproliferative Disorders;   Gestational Trophoblastic Tumor;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases;   Nausea and Vomiting;   Neuroblastoma;   Ovarian Cancer;   Testicular Germ Cell Tumor
Interventions: Drug: ondansetron hydrochloride;   Other: survey administration;   Procedure: autologous hematopoietic stem cell transplantation
16 Recruiting Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Conditions: Nausea and Vomiting;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: dexamethasone;   Drug: gabapentin;   Other: placebo
17 Recruiting Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer
Conditions: Nausea and Vomiting;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: dexamethasone;   Drug: dronabinol;   Drug: palonosetron hydrochloride;   Other: placebo
18 Recruiting Dexamethasone and Ondansetron or Palonosetron in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy for Early-Stage Breast Cancer
Conditions: Breast Cancer;   Nausea and Vomiting
Interventions: Drug: cyclophosphamide;   Drug: dexamethasone;   Drug: doxorubicin hydrochloride;   Drug: ondansetron;   Drug: palonosetron hydrochloride;   Procedure: quality-of-life assessment
19 Recruiting Blood Samples From Patients With Cancer Treated on a Clinical Trial to Control Nausea and Vomiting During Donor Stem Cell Transplant
Conditions: Breast Cancer;   Chronic Myeloproliferative Disorders;   Gestational Trophoblastic Tumor;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases;   Nausea and Vomiting;   Neuroblastoma;   Ovarian Cancer;   Testicular Germ Cell Tumor
Interventions: Other: immunoenzyme technique;   Other: laboratory biomarker analysis;   Other: medical chart review
20 Recruiting Phase 2 Study to Assess Efficacy, Tolerability & Safety of Intranasal Granisetron for Chemo-Induced Nausea & Vomiting
Condition: Chemotherapy-Induced Nausea and Vomiting
Intervention: Drug: TRG

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services